When is levemir being discontinued?

Short answer: There isn’t a global, announced discontinuation of Levemir (insulin detemir) as of my latest update. Availability can vary by country or market, and a product can be temporarily or regionally limited for various reasons.

If you’re asking about a specific country or situation (e.g., a note from your pharmacy or insurance), tell me your country and I’ll tailor the guidance.

How to verify the current status quickly:
- Check Novo Nordisk’s official site or investor relations announcements for any discontinuation notices.
- Look up the product in your country’s regulatory agency records (examples: FDA in the US, EMA/European Commission in the EU, MHRA in the UK, Health Canada, TGA in Australia).
- Ask your pharmacist or healthcare provider for the most up-to-date local status and recommended alternatives if needed.
- You can also check the product’s official labeling or National Drug Code (NDC) listings for notices about supply or discontinuation.

If Levemir were to be discontinued in your area, a clinician would typically help switch you to a comparable long-acting insulin (e.g., insulin glargine or insulin degludec) and provide dosing guidance. If you’d like, tell me your country and I can point you to the most relevant official sources.